Detalhe da pesquisa
1.
Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis.
Hepatology
; 79(2): 368-379, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625154
2.
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
J Hepatol
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479614
3.
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling.
Clin Gastroenterol Hepatol
; 22(4): 768-777.e8, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065374
4.
Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis.
Clin Gastroenterol Hepatol
; 21(12): 3080-3088.e9, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004974
5.
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
J Hepatol
; 76(1): 107-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34530063
6.
Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use disorder - an example of participatory research.
Digit Health
; 10: 20552076241242787, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715972
7.
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
PLoS One
; 17(4): e0265153, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385510
8.
Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome.
Hepatol Commun
; 6(8): 2121-2131, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535681